⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150290 | 0.80 | — | — | |
| SCHEMBL5985965 | 0.79 | — | — | |
| SCHEMBL5857075 | 0.79 | — | — | |
| SCHEMBL5986741 | 0.73 | FAAH (0.32) | — | |
| SCHEMBL3207594 | 0.73 | FAAH (0.32) | — | |
| SCHEMBL1677758 | 0.73 | — | — | |
| SCHEMBL1677761 | 0.73 | — | — | |
| SCHEMBL7296532 | 0.73 | — | — | |
| SCHEMBL7296058 | 0.73 | — | — | |
| SCHEMBL7296527 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193168-B2 | Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release | REDPOINT BIO CORPORATION (US) | 2012-06-05 | — | — | US | disclosed |
| EP-2107908-A2 | USE OF A TRPM5 INHIBITOR TO REGULATE INSULIN AND GLP-1 RELEASE | Redpoint Bio Corporation (US) | 2009-10-14 | — | — | EP | disclosed |
| EP-1951215-A4 | HYDRAZONE DERIVATIVES AND USES THEREOF | REDPOINT BIO CORP (US) | 2009-07-29 | — | — | EP | disclosed |
| US-20080306030-A1 | Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release | REDPOINT BIO CORPORATION (US) | 2008-12-11 | — | — | US | disclosed |
| WO-2008097504-A2 | USE OF A TRPM5 INHIBITOR TO REGULATE INSULIN AND GLP-1 RELEASE | REDPOINT BIO CORPORATION (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-1951215-A2 | HYDRAZONE DERIVATIVES AND USES THEREOF | Redpoint Bio Corporation (US) | 2008-08-06 | — | — | EP | disclosed |
| US-20070207093-A1 | Hydrazone derivatives and uses thereof | LINQUAGEN CORP. | 2007-09-06 | — | — | US | disclosed |
| WO-2007056159-A2 | HYDRAZONE DERIVATIVES AND USES THEREOF | REDPOINT BIO CORPORATION (US) | 2007-05-18 | — | — | WO | disclosed |
| US-5137889-A | Hypotensive agents; coronary vasodilators; calcium antagonists; antiinflammatory agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-08-11 | — | — | US | disclosed |
| US-5034395-A | Hypotensive agents, carboxylated dihydropyridines | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-07-23 | — | — | US | disclosed |
| EP-0145434-A2 | Novel dihydropyridine derivatives and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-06-19 | — | — | EP | disclosed |
| EP-0052916-B1 | ERODIBLE POLYMER CONTAINING EROSION RATE MODIFIER | ALZA CORPORATION (US) | 1985-01-02 | — | — | EP | disclosed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | disclosed |
| EP-0052916-A2 | Erodible polymer containing erosion rate modifier | ALZA CORPORATION (US) | 1982-06-02 | — | — | EP | disclosed |
| US-4322323-A | Erodible device comprising surfactant for modifying the rate of erosion of the device | ALZA CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4180646-A | BIOERODABLE SUSTAINED RELEASE COTAINGS | ALZA CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
| US-4138344-A | Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4131648-A | POLYMERIC MATERIALS | ALZA CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
| US-4093709-A | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |